Cytomegalovirus Disease Completed Phase 4 Trials for Valganciclovir (DB01610)

Back to Cytomegalovirus Disease

Also known as: Cytomegaloviral disease, unspecified / Cytomegalovirus Infections / Cytomegalovirus infection / Cytomegalovirus infection (disorder) / Cytomegalic inclusion disease / Cytomegaloviral disease / CMV infection / Cytomegaloviral infections

Indication	Status	Phase
DBCOND0042800 (Cytomegalovirus Disease)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01509404	Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection	Prevention	Human cytomegalovirus immune globulin (DB13886) Valganciclovir (DB01610)